The International Society of Anti-Infective Pharmacology is an interdisciplinary scientific society for the study of pharmacodynamics and pharmacokinetics and for the improvement of dosing of anti-infectives. The Society efforts are focused on expanding basic and applied knowledge in this area of chemotherapeutics through the organization of symposia, discussion workshops , and educational workshops with international participation, in connection with major scientific meetings dealing with the chemotherapy of infectious diseases (ICAAC, ICC, ECCMID ...), and other scientific societies with common interests, and Regulatory Authorities (FDA, EMEA). The current membership of the Society is about 120 worldwide.
Organization
Past activities and documents
 Membership/Services

ICAAC workshops

Friday, September 11, 2009, at the Hilton San Francisco, 333 O'Farrell Street, San Francisco, CA

Registration

Workshop 1 (49-1)
8:30 a.m. - Noon
Workshop 2 (49-2)
1:00 - 4:30 p.m.
Workshop 3 (49-3)
8:30 a.m. - Noon
Workshop 4 (49-4)
1:00 - 4:30 p.m.
Basics of Pharmacokinetics and Pharmacodynamics of Anti-infective Agents Clinical Relevance of Pharmacokinetics and Pharmacodynamics of Anti-infective Agents Inroduction to PK/PD Modeling of Anti-infective Agents Advanced PK/PD Modeling of Anti-infective Agents

Conveners:
Johan W. Mouton, MD, PhD; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands.
Hartmut Derendorf, PhD; Univ. of Florida, Gainesville, FL.

Conveners:
Johan W. Mouton, MD, PhD; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands.
Ursula Theuretzbacher, PhD; Center for Anti-Infective Agents, Vienna, Austria.

Conveners:
Vincent Tam, PharmD; Univ. of Houston, TX.
Alexander Vinks, PhD; Cincinnati, OH.

 Conveners:
George Drusano, MD; Ordway Research, Albany, NY.
Hartmut Derendorf, PhD; University of Florida, Gainesville, FL

Faculty:

William A. Craig, MD; William S. Middleton Mem. VA Hosp., Madison, WI.
Hartmut Derendorf, PhD; Univ. of Florida, Gainesville, FL.
Alasdair P. MacGowan, MD; Bristol Center for Antimicrobial Research, Bristol, UK.
Johan W. Mouton, MD, PhD; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands.
Ursula Theuretzbacher, PhD; Center for Anti-Infective Agents, Vienna, Austria.

 

Faculty:

David R. Andes, MD; Univ. Wisconsin, Madison, WI.
Paul Ambrose, PharmD, FIDSA; ICPD/Ordway Research Institute, Albany, NY.
Johan W. Mouton, MD, PhD; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands.
Ursula Theuretzbacher, PhD; Center for Anti-Infective Agents, Vienna, Austria .
Paul M. Tulkens, MD; Univ. Louvain, Brussels, Belgium.
Markus Zeitlinger, MD; Medical Univ. Vienna, Vienna, Austria.

Faculty:

Sujata M. Bhavnani, PharmD, MS; ICPD/Ordway Research Institute, Albany, NY.
Alan Forrest, PharmD; SUNY, University of Buffalo, NY.
Vincent Tam, PharmD; Univ. of Houston, TX.
Alasdair P. MacGowan, MD; Bristol Center for Antimicrobial Research, Bristol, UK.
David Nicolau, PharmD; Hartford Hospital, Hartford, CT.
Alexander Vinks, PharmD, PhD; Univ. of Cincinnati, OH.

Faculty:

Hartmut Derendorf, PhD; Univ. of Florida, Gainesville, FL.
Alan Forrest, PharmD; SUNY, University of Buffalo, NY
Jürgen Bulitta, PhD; SUNY, University of Buffalo, NY
George Drusano, MD; Ordway Research, Albany, NY.
Schedule:

8:30 - 8:40 am - Conveners Introduction
8:40 – 9:10 am - H. Derendorf: Introduction to PK/PD
9:10 – 9:40 am - J. Mouton: PK/PD indices
9:40 - 10:10 am - U. Theuretzbacher: Protein Binding/Tissue Distribution
10:10 - 10:30 am - Break
10:30 – 11:00 am - J. Mouton: In vitro models
11:00 - 11:30 am - W. Craig: Animal models
11:30 – 12:00 am - A. MacGowan: In vitro resistance

Schedule:

1:00 – 1:10 pm - Conveners Introduction
1:10 – 1:40 pm - J. Mouton: Clinical applications of PK/PD
1:40 – 2:10 pm - M. Zeitlinger: Drug exposure at infection site
2:10 – 2:40 pm - P. Ambrose: Clinical study design based on PK/PD
2:40 – 3:00 pm - Break
3:00 – 3:30 pm - D. Andes: PK/PD of antifungals
3:30 – 4:00 pm - U. Theuretzbacher: Clinical resistance
4:00 – 4:30 pm - P. Tulkens: Dosing in specific situations

Schedule:

8:30 - 8:40 am - Conveners Introduction
8:40 – 9:10 am - A. MacGowan: Approach to clinical breakpoints
9:10 – 9:40 am - V. Tam: PK/PD modeling of resistance
9:40 - 10:10 am - D. Nicolau: PK/PD approaches in drug development
10:10 - 10:30 am - Break
10:30 – 11:00 am - A. Vinks: Population PK/PD modeling of anti-infective agents
11:00 - 11:30 am - A. Forrest: Modeling of anti-infective activity
11:30 – 12:00 am -S. Bhavnani: Monte Carlo Simulations

Schedule:

1:00 – 1:10 pm - Conveners Introduction
1:10 – 1:55 pm - H. Derendorf: PK/PD based on kill curves
1:55 – 2:40 pm - A. Forrest: Modeling of anti-infective activity
2:40 – 3:00 pm - Break
3:00 – 3:45 pm - G. Drusano: PK/PD in drug development
3:45 – 4:30 pm - J. Bulitta: PK/PD models of resistance